Tag: Health

Impact Newswire brings you the latest in Health news

servier
Europe

Servier appoints David K. Lee to Executive Committee

Press Release – 13 January 2025 – Suresnes (France), January 13th, 2025 – Servier, an independent international pharmaceutical group, announces the appointment of David K. Lee to its Executive Committee as Executive Vice President for the United States, effective January 1, 2025. David K. Lee has held the position of Chief Executive Officer (CEO) of Servier Pharmaceuticals in the United States since the creation of … Continue reading Servier appoints David K. Lee to Executive Committee

Impact Newswire
MERGE
United States

MERGE Appoints Stephanie Trunzo as CEO

Visionary Oracle Executive to Guide Company’s Emphasis on Meaningful Engagement at the Intersection of Consumerism and Health Press Release – CHICAGO – January 9, 2025 – MERGE, a leading hybrid marketing and technology solutions firm, today announced the appointment of Stephanie Trunzo as its new Chief Executive Officer. Previously a Senior Vice President and General Manager at Oracle, and a recent addition to MERGE’s board … Continue reading MERGE Appoints Stephanie Trunzo as CEO

Impact Newswire
hovione
Europe

Hovione strengthens its global position as a top employer for the third consecutive year

Hovione has once again solidified its position as a top employer. Press Release – Jan 16, 2025 Lisbon, January 16, 2025 – Hovione, an international integrated pharmaceutical development and manufacturing organization, has once again solidified its position as a top employer. For the third consecutive year, all four of its manufacturing sites – Lisbon (Portugal), Cork (Ireland), East Windsor (NJ, USA), and Macau – have been … Continue reading Hovione strengthens its global position as a top employer for the third consecutive year

Impact Newswire
ISG
United States

AI Solutions for Visually Impaired, AI Search and AI Agents Win ISG Startup Challenges

Audiences vote Artha France, Scrunch AI and Instruct top tech pitches at ISG events in Paris, Dallas and London Press Release – January 10, 2025 – STAMFORD, Conn. – AI-powered solutions for addressing visual impairments, optimizing brands for AI search and creating AI agents won the ISG Startup Challenges at recent events in Paris, Dallas and London hosted by Information Services Group (ISG) (Nasdaq: III), a … Continue reading AI Solutions for Visually Impaired, AI Search and AI Agents Win ISG Startup Challenges

Impact Newswire
JOHNSON & JOHNSON
United States

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizophrenia in adults sNDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has potential to become a standard of care for most common depressive disorders CAPLYTA® adds to Johnson & Johnson’s robust lineup of … Continue reading Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

Impact Newswire